RxDoctor Payments Data

Megan Olson

Nurse Practitioner · Columbus, OHNPI 1235515180

Payments from drug & device makers

$2,833in general payments, 2019–2025

Across 146 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$983
  • Viiv Healthcare Company$894
  • Merck$271
  • Exact Sciences$212
  • Johnson & Johnson$70
  • AbbVie$64
  • plus $339 from 12 others

What the payments were for

  • Food & beverage$2,80099%
  • Education$331%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,833 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala110$429,831
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf32$146,887
TivicayDolutegravir Sodium39$101,196
DescovyEmtricitabine/Tenofov Alafenam24$66,476
JulucaDolutegravir/Rilpivirine15$44,057
DelstrigoDoravirine/Lamivu/Tenofov Diso12$30,229
TrulicityDulaglutide26$27,680
OzempicSemaglutide21$19,872
PrezcobixDarunavir/Cobicistat11$18,622
RybelsusSemaglutide13$11,839
XareltoRivaroxaban13$10,729
Tresiba Flextouch U-100Insulin Degludec13$10,251
Abacavir-LamivudineAbacavir Sulfate/Lamivudine19$9,472
Incruse ElliptaUmeclidinium Bromide18$9,346
JardianceEmpagliflozin15$8,141

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Descovy$983$496,307134 claims
Viiv Healthcare CompanyTivicay, Juluca$894$145,25254 claims
MerckDelstrigo, Belsomra$271$35,43924 claims
Johnson & JohnsonPrezcobix, Xarelto$70$29,35124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →